LEUCI, ROSALBA
 Distribuzione geografica
Continente #
NA - Nord America 1.584
AS - Asia 879
EU - Europa 823
SA - Sud America 182
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 46
Totale 3.675
Nazione #
US - Stati Uniti d'America 1.482
IT - Italia 401
SG - Singapore 344
CN - Cina 154
BR - Brasile 145
HK - Hong Kong 98
RU - Federazione Russa 98
VN - Vietnam 85
DE - Germania 71
IN - India 65
FR - Francia 61
BD - Bangladesh 50
CA - Canada 50
GB - Regno Unito 47
SE - Svezia 46
ID - Indonesia 24
AT - Austria 16
FI - Finlandia 15
TR - Turchia 13
AR - Argentina 12
PL - Polonia 12
MX - Messico 11
ZA - Sudafrica 10
IQ - Iraq 9
EC - Ecuador 8
LT - Lituania 8
MA - Marocco 8
PR - Porto Rico 8
PT - Portogallo 8
CI - Costa d'Avorio 7
ES - Italia 7
JP - Giappone 7
NL - Olanda 7
CO - Colombia 6
SV - El Salvador 6
CH - Svizzera 5
CL - Cile 5
PH - Filippine 5
TT - Trinidad e Tobago 5
UA - Ucraina 5
AL - Albania 4
CR - Costa Rica 4
EG - Egitto 4
JM - Giamaica 4
NI - Nicaragua 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CW - ???statistics.table.value.countryCode.CW??? 3
GP - Guadalupe 3
GT - Guatemala 3
KE - Kenya 3
OM - Oman 3
SC - Seychelles 3
SN - Senegal 3
GA - Gabon 2
IE - Irlanda 2
IL - Israele 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 3.517
Città #
San Jose 226
Ashburn 199
Singapore 181
Council Bluffs 112
Hong Kong 93
Chandler 69
Beijing 67
Milan 65
Nyköping 45
New York 42
Santa Clara 38
Los Angeles 36
Dallas 33
Ho Chi Minh City 32
Bari 27
Rome 26
Naples 25
Hanoi 22
Fragagnano 21
Munich 21
Frankfurt am Main 18
Lauterbourg 18
Atlanta 17
Chicago 17
Fairfield 17
Falkenstein 16
Marseille 16
Jakarta 15
Montreal 15
São Paulo 15
Chennai 14
Helsinki 13
Houston 13
Brooklyn 12
Moscow 12
Seattle 12
Columbus 11
London 11
Redondo Beach 11
Warsaw 11
Cambridge 10
Denver 10
Lawrence 10
North Bergen 10
Poplar 10
San Francisco 10
Boardman 9
Kolkata 9
Roxbury 9
Inglewood 8
Lisbon 8
Abidjan 7
Bologna 7
Buffalo 7
Figino 7
Johannesburg 7
Langenzersdorf 7
Nuremberg 7
Orem 7
Patna 7
Tokyo 7
Wilmington 7
Woodbridge 7
Brasília 6
Elk Grove Village 6
Florence 6
San Salvador 6
Belo Horizonte 5
Boston 5
Boydton 5
Brindisi 5
Cleveland 5
Gravina in Puglia 5
Phoenix 5
Rio de Janeiro 5
Toronto 5
Washington 5
Wuxi 5
Ancona 4
Bandung 4
Charlotte 4
Da Nang 4
Düsseldorf 4
Guarulhos 4
Lucca 4
Managua 4
Manchester 4
Mexico City 4
Molfetta 4
Ottawa 4
Salerno 4
San Antonio 4
San José 4
Turin 4
Vienna 4
Ankara 3
Ann Arbor 3
Araras 3
Bitonto 3
Brampton 3
Totale 2.013
Nome #
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders 185
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 146
A Chemical Modification of a Peroxisome Proliferator-Activated Receptor Pan Agonist Produced a Shift to a New Dual Alpha/Gamma Partial Agonist Endowed with Mitochondrial Pyruvate Carrier Inhibition and Antidiabetic Properties 144
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 139
A Chemoinformatics Search for Peroxisome Proliferator-Activated Receptors Ligands Revealed a New Pan-Agonist Able to Reduce Lipid Accumulation and Improve Insulin Sensitivity 131
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 129
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 122
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition 120
A NEW ANTIDIABETIC AGENT SHOWING PPARα/γ DUAL AGONISM AND MITOCHONDRIAL PYRUVATE CARRIER INHIBITION 117
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 110
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding 108
Can foods influence the onset and progress of neurodegenerative diseases? 107
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 105
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy 98
3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate 96
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 86
Role of copper chelating agents: between old applications and new perspectives in neuroscience 85
IDENTIFICATION OF A NOVEL PPARRα/γ DUAL AGONIST SHOWING ANTIDIABETIC EFFECTS AND ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF PPARγ 85
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 84
From classical MTDLs to a semi-synthetic innovative green approach: nature-inspired design as a new intriguing opportunity for new anti-Alzheimer’s drugs 83
Repurposing Rivastigmine Anti-AD Drug By Aryloxyacetic Hybridization: Biometal Chelation And Potential Increased Anti-Amyloidogenic Ability 82
New rivastigmine-like compounds for the potential treatment of Alzheimer’s disease: a multi-target approach 71
Nature-inspired structures for the multi-target treatment of Alzheimer’s disease: a successful approach for drug design 67
Sustainable valorization of grape pomace as source of nutraceuticals 65
Multi-target approach for the treatment of chronic and degenerative diseases 65
Deep Eutectic Solvents (DESs) as Alternative Sustainable Media for the Extraction and Characterization of Bioactive Compounds from Winemaking Industry Wastes 64
Rivastigmine-based hybrids: a multi-target approach to anti-Alzheimer’s drug design 63
N-(2-(Benzylamino)ethyl)-4-(naphthalene-1-sulfonamido)benzamide 62
Green solvents as an alternative, sustainable practice for the recovery of phenolic compounds in grape pomace 61
A new series of rivastigmine structure-based hybrids for a multi-target approach to Alzheimer’s disease 61
New phenothiazine-donepezil like hybrids as potential Alzheimer’s disease multitarget drugs with antioxidant properties 58
PROTEIN MISFOLDING AND AGGREGATION CONTROL AS THE KEY TARGETS FOR INNOVATIVE MULTIFUNCTIONAL ANTI-AD SMALL MOLECULES-BASED DRUGS 57
A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model 52
Grape pomace as a valuable source of nutraceuticals in Deep Eutectic Solvents ready-to-use extracts 43
2- Aryloxymethylene-substituted scaffolds as privileged moieties for the design of new potential metal chelators in the multi-target therapy of Alzheimer's disease 38
Valorisation of grape pomace as source of bioactive compounds in Deep Eutectic Solvents ready-to-use extracts 38
Novel rivastigmine structure-based hybrids for the potential treatment of Alzheimer’s disease 37
Nature-inspired design of new anti-Alzheimer’s multi-target drugs: the NInFA project 34
Deep Eutectic Solvents as Convenient Media for the Preparation of Semi-synthetic Anti-AD Multi-Target Hybrids 34
Sustainable Solutions for the Production of New Feed Supplements From Wine Industry Waste 34
Green methods for the recovery of bioactive molecules from natural sources 33
New rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer drugs 28
Improved 2-aryloxymethylene moieties as novel potential chelators for the multi-target treatment of Alzheimer’s disease 25
Evaluation of the effects of halogens on the anti-cholinesterase activity of potent multi-targeted hybrids designed for the treatment of Alzheimer's disease 24
Leveraging nature as source of potential anti-Alzheimer’s drugs: The NInFA project 22
Grape pomace as an alternative source for the sustainable production of polyphenol-rich extracts 19
Edible Natural Deep Eutectic Solvents (NADESs)-Based Polyphenolic Extracts: An Eco-Sustainable Alternative for Grape Pomace Valorization 18
A sustainable and semi-synthetic strategy for the discovery of novel multi-target anti-Alzheimer's agents 18
Deep eutectic solvents-based extracts from grape pomace for the production of green alternative food and feed supplements 18
New chalcogen-optimized 1,3,5-triazines as dual 5-HT6R/FAAH modulators: A versatile approach to neurodegenerative disorders 14
NADES-based green extraction of grape pomace polyphenols: a sustainable approach to novel dietary supplements 14
Synthesis and preliminary pharmacological characterization of novel fibrate derivatives as PPAR agonists for the prospective management of metabolic dysfunction-associated disorders 13
Enhanced chelating agent with multi-target activity potentially useful for the treatment of Alzheimer’s Disease 11
From fungal metabolites to multi-target ligands: a nature-inspired and green semi-synthetic strategy for Alzheimer’s disease drug discovery 11
Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity 11
Multitarget hybrid small molecules for metal chelation with additive cholinesterase inhibitory and antioxidant properties in alzheimer’s disease 11
Sustainable synthesis and biological evaluation of tacrine-like multi-target hybrids as anti-Alzheimer candidates 10
Structural optimization of donepezil-like hybrids toward an improved multi-target and ADME-related profile 5
Rapid HPLC-Based ADME Profiling of Novel Donepezil and Rivastigmine Analogues for Potential Application in Alzheimer’s Disease 4
Totale 3.675
Categoria #
all - tutte 14.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202252 0 0 0 0 0 8 0 3 7 5 11 18
2022/2023184 11 29 8 10 14 29 1 27 38 6 5 6
2023/2024136 9 16 6 3 15 35 6 1 14 10 6 15
2024/2025762 59 30 53 38 43 33 104 78 31 62 77 154
2025/20261.764 197 81 76 259 241 81 122 64 230 188 126 99
2026/2027702 73 125 209 295 0 0 0 0 0 0 0 0
Totale 3.675